MAPT and Alzheimer disease: Besides β-amyloid and tau, which capture only a portion of the biological mechanisms underlying AD, there is a growing appreciation for the co-occurrence of other concurrent pathologic insults, and an understanding that a more comprehensive or upstream approach is necessary to address the heterogeneous pathologies underlying AD.